Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Executive Summary

Shareholders in Concord, Calif.-based peritioneal dialysis products firm on Aug. 30 approved merger plan with Fresenius USA that was announced Feb. 14 ("The Pink Sheet" Feb. 19, "In Brief"). New plan replaces one announced as preliminary agreement in June 1989 that was thrown out due to a break in Delmed's supply contract with National Medical Care ("The Pink Sheet" Oct. 30, 1989, T&G-9). Pursuant to plan, Fresenius USA and German parent Fresenius AG purchased $ 5 mil. in options to boost their equity stake in Delmed to approximately 80%, Delmed agreed to increase number of authorized shares from 100 mil. to 300 mil. and to increase number of issuable shares from 1.1 mil. to 5 mil.



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts